跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retazol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retazol
Approved
STANDARD
Retazol
Shijiazhuang No.4 Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
940f471c05095873
Company
Shijiazhuang No.4 Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
940f471c05095873
Drug Approval Philippines Name
Retazol
Product Name
Retazol
Registration Number
DRP-5460-05
Brand Name
Retazol
Generic Name
Metronidazole
Dosage Form
Solution for I.V. Infusion
Dosage Strength
5mg/mL (500mg/100 mL)
Manufacturer
Shijiazhuang No.4 Pharmaceutical Co., Ltd
Importer
Aglobal Care, Inc.
Distributor
Reta Drug
Issuance Date
29 May 2023
Expiry Date
31 July 2028
Pharmacologic Category
Antibacterial (Nitroimidazole) / Antiprotozoal (Amebicide)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
940f471c05095873
Type
Standard
Back to Philippines FDA Approvals